Document Type : Letter(s) to the Editor
Authors
- Marzhan Aitmagambetova 1
- Anar Tulyayeva 1
- Arip Koishybaev 1
- Elena Zholdybayeva 2
- Saule Balmagambetova 1
- Nurgul Kereyeva 1
- Dinara Zholmukhamedova 1
- Nurgul Ablakimova 3, 4
1 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
2 National Center for Biotechnology, Astana, Kazakhstan
3 Department of Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
4 Department of Hospital Pharmacy, Regional Perinatal Center, Aktobe, Kazakhstan
Abstract
Despite significant advances in medicine, food preservation methods, and Helicobacter pylori (H. pylori) treatment, gastric cancer remains the fifth most common type of cancer and the fourth leading cause of cancer-related deaths worldwide, accounting for over a million new cases and nearly 770,000 deaths in 2020.
Keywords
- Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 2022;47:101404. doi: 10.1016/j.eclinm.2022.101404. PubMed PMID: 35497064; PubMed Central PMCID: PMCPMC9046108.
- Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM, Vicini E, et al. CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. J Med Genet. 2022;59:313-7. doi: 10.1136/jmedgenet-2021-108226. PubMed PMID: 34952833.
- Li J. Gastric Cancer in Young Adults: A Different Clinical Entity from Carcinogenesis to Prognosis. Gastroenterol Res Pract. 2020;2020:9512707. doi: 10.1155/2020/9512707. PubMed PMID: 32190044; PubMed Central PMCID: PMCPMC7071806.
- Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. doi: 10.3389/fphar.2018.01421. PubMed PMID: 30568591; PubMed Central PMCID: PMCPMC6290068.
- Moehler M, Al-Batran SE, Andus T, Arends J, Arnold D, Baretton G, et al. S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL. Z Gastroenterol. 2019;57:1517-632. doi: 10.1055/a-1018-2516. PubMed PMID: 31826284.
)